Cargando…

Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57

BACKGROUND: Transient neonatal diabetes mellitus 1 (TNDM1) is a rare imprinting disorder characterized by intrautering growth retardation and diabetes mellitus usually presenting within the first six weeks of life and resolves by the age of 18 months. However, patients have an increased risk of deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Bak, Mads, Boonen, Susanne E., Dahl, Christina, Hahnemann, Johanne M. D., Mackay, Deborah J. D. G., Tümer, Zeynep, Grønskov, Karen, Temple, I. Karen, Guldberg, Per, Tommerup, Niels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831126/
https://www.ncbi.nlm.nih.gov/pubmed/27075368
http://dx.doi.org/10.1186/s12881-016-0292-4
_version_ 1782427011823697920
author Bak, Mads
Boonen, Susanne E.
Dahl, Christina
Hahnemann, Johanne M. D.
Mackay, Deborah J. D. G.
Tümer, Zeynep
Grønskov, Karen
Temple, I. Karen
Guldberg, Per
Tommerup, Niels
author_facet Bak, Mads
Boonen, Susanne E.
Dahl, Christina
Hahnemann, Johanne M. D.
Mackay, Deborah J. D. G.
Tümer, Zeynep
Grønskov, Karen
Temple, I. Karen
Guldberg, Per
Tommerup, Niels
author_sort Bak, Mads
collection PubMed
description BACKGROUND: Transient neonatal diabetes mellitus 1 (TNDM1) is a rare imprinting disorder characterized by intrautering growth retardation and diabetes mellitus usually presenting within the first six weeks of life and resolves by the age of 18 months. However, patients have an increased risk of developing diabetes mellitus type 2 later in life. Transient neonatal diabetes mellitus 1 is caused by overexpression of the maternally imprinted genes PLAGL1 and HYMAI on chromosome 6q24. One of the mechanisms leading to overexpression of the locus is hypomethylation of the maternal allele of PLAGL1 and HYMAI. A subset of patients with maternal hypomethylation at PLAGL1 have hypomethylation at additional imprinted loci throughout the genome, including GRB10, ZIM2 (PEG3), MEST (PEG1), KCNQ1OT1 and NESPAS (GNAS-AS1). About half of the TNDM1 patients carry mutations in ZFP57, a transcription factor involved in establishment and maintenance of methylation of imprinted loci. Our objective was to investigate whether additional regions are aberrantly methylated in ZFP57 mutation carriers. METHODS: Genome-wide DNA methylation analysis was performed on four individuals with homozygous or compound heterozygous ZFP57 mutations, three relatives with heterozygous ZFP57 mutations and five controls. Methylation status of selected regions showing aberrant methylation in the patients was verified using bisulfite-sequencing. RESULTS: We found large variability among the patients concerning the number and identity of the differentially methylated regions, but more than 60 regions were aberrantly methylated in two or more patients and a novel region within PPP1R13L was found to be hypomethylated in all the patients. The hypomethylated regions in common between the patients are enriched for the ZFP57 DNA binding motif. CONCLUSIONS: We have expanded the epimutational spectrum of TNDM1 associated with ZFP57 mutations and found one novel region within PPP1R13L which is hypomethylated in all TNDM1 patients included in this study. Functional studies of the locus might provide further insight into the etiology of the disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12881-016-0292-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4831126
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48311262016-04-15 Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57 Bak, Mads Boonen, Susanne E. Dahl, Christina Hahnemann, Johanne M. D. Mackay, Deborah J. D. G. Tümer, Zeynep Grønskov, Karen Temple, I. Karen Guldberg, Per Tommerup, Niels BMC Med Genet Research Article BACKGROUND: Transient neonatal diabetes mellitus 1 (TNDM1) is a rare imprinting disorder characterized by intrautering growth retardation and diabetes mellitus usually presenting within the first six weeks of life and resolves by the age of 18 months. However, patients have an increased risk of developing diabetes mellitus type 2 later in life. Transient neonatal diabetes mellitus 1 is caused by overexpression of the maternally imprinted genes PLAGL1 and HYMAI on chromosome 6q24. One of the mechanisms leading to overexpression of the locus is hypomethylation of the maternal allele of PLAGL1 and HYMAI. A subset of patients with maternal hypomethylation at PLAGL1 have hypomethylation at additional imprinted loci throughout the genome, including GRB10, ZIM2 (PEG3), MEST (PEG1), KCNQ1OT1 and NESPAS (GNAS-AS1). About half of the TNDM1 patients carry mutations in ZFP57, a transcription factor involved in establishment and maintenance of methylation of imprinted loci. Our objective was to investigate whether additional regions are aberrantly methylated in ZFP57 mutation carriers. METHODS: Genome-wide DNA methylation analysis was performed on four individuals with homozygous or compound heterozygous ZFP57 mutations, three relatives with heterozygous ZFP57 mutations and five controls. Methylation status of selected regions showing aberrant methylation in the patients was verified using bisulfite-sequencing. RESULTS: We found large variability among the patients concerning the number and identity of the differentially methylated regions, but more than 60 regions were aberrantly methylated in two or more patients and a novel region within PPP1R13L was found to be hypomethylated in all the patients. The hypomethylated regions in common between the patients are enriched for the ZFP57 DNA binding motif. CONCLUSIONS: We have expanded the epimutational spectrum of TNDM1 associated with ZFP57 mutations and found one novel region within PPP1R13L which is hypomethylated in all TNDM1 patients included in this study. Functional studies of the locus might provide further insight into the etiology of the disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12881-016-0292-4) contains supplementary material, which is available to authorized users. BioMed Central 2016-04-14 /pmc/articles/PMC4831126/ /pubmed/27075368 http://dx.doi.org/10.1186/s12881-016-0292-4 Text en © Bak et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Bak, Mads
Boonen, Susanne E.
Dahl, Christina
Hahnemann, Johanne M. D.
Mackay, Deborah J. D. G.
Tümer, Zeynep
Grønskov, Karen
Temple, I. Karen
Guldberg, Per
Tommerup, Niels
Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57
title Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57
title_full Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57
title_fullStr Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57
title_full_unstemmed Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57
title_short Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57
title_sort genome-wide dna methylation analysis of transient neonatal diabetes type 1 patients with mutations in zfp57
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831126/
https://www.ncbi.nlm.nih.gov/pubmed/27075368
http://dx.doi.org/10.1186/s12881-016-0292-4
work_keys_str_mv AT bakmads genomewidednamethylationanalysisoftransientneonataldiabetestype1patientswithmutationsinzfp57
AT boonensusannee genomewidednamethylationanalysisoftransientneonataldiabetestype1patientswithmutationsinzfp57
AT dahlchristina genomewidednamethylationanalysisoftransientneonataldiabetestype1patientswithmutationsinzfp57
AT hahnemannjohannemd genomewidednamethylationanalysisoftransientneonataldiabetestype1patientswithmutationsinzfp57
AT mackaydeborahjdg genomewidednamethylationanalysisoftransientneonataldiabetestype1patientswithmutationsinzfp57
AT tumerzeynep genomewidednamethylationanalysisoftransientneonataldiabetestype1patientswithmutationsinzfp57
AT grønskovkaren genomewidednamethylationanalysisoftransientneonataldiabetestype1patientswithmutationsinzfp57
AT templeikaren genomewidednamethylationanalysisoftransientneonataldiabetestype1patientswithmutationsinzfp57
AT guldbergper genomewidednamethylationanalysisoftransientneonataldiabetestype1patientswithmutationsinzfp57
AT tommerupniels genomewidednamethylationanalysisoftransientneonataldiabetestype1patientswithmutationsinzfp57